Breaking News Instant updates and real-time market news.

AMD

AMD

$14.40

0.91 (6.75%)

, MU

Micron

$26.21

0.41 (1.59%)

07:36
03/21/17
03/21
07:36
03/21/17
07:36

Unusual call flow in option market yesterday

Notable call activity was cited Monday in AMD (AMD), Micron (MU), Weatherford (WFT), CSX (CSX), Dollar Tree (DLTR), FireEye (FEYE), Rio Tinto (RIO), Melco Crown (MPEL), Globalstar (GSAT), and Fortive (FTV).

AMD

AMD

$14.40

0.91 (6.75%)

MU

Micron

$26.21

0.41 (1.59%)

WFT

Weatherford

$6.18

0.03 (0.49%)

CSX

CSX

DLTR

Dollar Tree

$74.30

-1.4 (-1.85%)

FEYE

FireEye

$11.61

0.88 (8.20%)

RIO

Rio Tinto

$43.26

0.23 (0.53%)

MPEL

Ticker changed to MLCO

$18.65

0.1 (0.54%)

GSAT

Globalstar

$1.57

0.1 (6.80%)

FTV

Fortive

$59.00

-0.58 (-0.97%)

  • 21

    Mar

  • 23

    Mar

  • 28

    Mar

  • 29

    Mar

  • 30

    Mar

  • 06

    Apr

AMD AMD
$14.40

0.91 (6.75%)

03/09/17
ADAM
03/09/17
NO CHANGE
Target $17
ADAM
Buy
AMD price target raised to $17 from $14 at Canaccord
Canaccord analyst Matthew Ramsay raised his price target on AMD (AMD) to $17 from $14 following investor meetings with CEO Lisa Su. Ramsay said the company is re-emerging as a competitive second source to Intel (INTC), its gradual GPU unit share recovery should be supplemented by the Vega launch in higher value tier markets, and the company is focused on delivering a multi-generational roadmap with the customer backing and foundry partners to do so. Ramsay reiterated his Buy rating on AMD shares.
02/22/17
RSBL
02/22/17
INITIATION
Target $16.5
RSBL
Buy
AMD initiated with a Buy at Rosenblatt
Rosenblatt analyst Hans Mosesmann initiated AMD with a Buy rating and $16.50 target.
03/20/17
JEFF
03/20/17
NO CHANGE
Target $16
JEFF
Buy
Jefferies sees more share gains for AMD, ups target to $16
Jefferies analyst Mark Lipacis raised his price target for AMD (AMD) to $16 from $13 citing better visibility into the Ryzen 7 high-performance and Ryzen 5 power-performance desktop processor launch. The chipmaker closed Friday down 16c to $13.49. As AMD continues to roll out its Ryzen product offerings, incremental share gains will continue to expand in the near term, Lipacis tells investors in a research note. He believes the company's "ability to price between-the-seams" while achieving competitive performance will result in "meaningful" share gains from Intel (INTC) in the Desktop, Server, and Notebook markets starting in 2017. The analyst upped his estimates for AMD and keeps a Buy rating on the shares.
02/21/17
MKMP
02/21/17
INITIATION
Target $13
MKMP
Neutral
AMD assumed with a Neutral at MKM Partners
MKM Partners assumed coverage on AMD with a Neutral and a $13 price target.
MU Micron
$26.21

0.41 (1.59%)

03/02/17
NEED
03/02/17
NO CHANGE
Target $42
NEED
Buy
Micron price target raised to $42 from $33 at Needham
Needham analyst Rajvindra Gill raised his price target on Micron to $42 following the company's positive preannouncement.
03/14/17
NEED
03/14/17
DOWNGRADE
NEED
Hold
Mobileye downgraded to Hold from Buy at Needham
Needham analyst Rajvindra Gill downgraded Mobileye (MBLY) to Hold from Buy after Intel (INTC) announced its intention to acquire all of the former's outstanding ordinary shares for $63.54 per share. The analyst believes the deal clearly validates the ADAS and fully autonomous vehicle market, and views it as a positive read-through into the entire ADAS and automotive supply chain, namely ON Semiconductor (ON), Micron (MU), Cypress Semiconductor (CY), NXP Semiconductors (NXPI), NVIDIA (NVDA), Tower Semiconductor (TSEM), and Infineon (IFNNY).
03/20/17
NOMU
03/20/17
NO CHANGE
NOMU
Investors overly concerned about DRAM spot price impact on Micron, says Nomura
Nomura analyst Romit Shah says that DRAM spot prices "flattened" over the last month and fell almost 2% last week. The analyst believes that investors are too focused on DRAM pricing trends' impact on Micron ,and he says that the performance of the stock has tended to correlate with its operating margin. The analyst thinks that the company's operating margin during its May quarter will reach 26%, which, based on historical norms, should result in a share price of $32, versus the stock's current level of $25.80. Shah keeps a Buy rating on the shares.
03/02/17
STFL
03/02/17
NO CHANGE
Target $40
STFL
Buy
Micron price target raised to $40 from $34 at Stifel
Stifel analyst Kevin Cassidy raised his price target on Micron to $40 after the company raised its guidance for its Q2 earnings, revenue and gross margin. The firm has a Buy rating on Micron shares.
WFT Weatherford
$6.18

0.03 (0.49%)

03/07/17
03/07/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Hyatt (H) upgraded to Equal Weight from Underweight at Morgan Stanley with analyst Thomas Allen saying shares are trading in-line with his price target adn offer more attractive risk/reward. 2. Noble Corp. (NE) upgraded to Buy from Neutral at Seaport Global with analyst Mark Brown citing valuation and expectations for a pickup in drilling later in 2017. 3. Weatherford (WFT) upgraded to Overweight from Equalweight at Capital One with analyst Luke Lemoine saying the hiring of Mark McCollum, Halliburton's (HAL) CFO, adds legitimacy and credibility to Weatherford's status as a turnaround story. 4. Bill Barrett (BBG) upgraded to Buy from Hold at Canaccord with analyst Stephen Berman saying he sees strong 2018 growth, a solid liquidity position, and said shares are almost 50% from its 52-week high. 5. TSMC (TSM) upgraded to Buy from Hold at HSBC with analyst Steven Pelayo saying he believes TSMC is reasserting its technology leadership. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/07/17
SPHN
03/07/17
NO CHANGE
SPHN
Underweight
Weatherford new CEO 'a step in the right direction,' says Stephens
Stephens analyst Christopher Denison says the addition of Mark McCollum as President and CEO of Weatherford is "a step in the right direction" toward improving the company's focus on operational execution. However, the analyst reiterates an Underweight rating on the shares as delivering on the previously announced multi-year strategic initiatives is important before becoming more positive, and as longer-term challenges associated with the balance sheet and product offerings loom relative to better-capitalized peers.
03/08/17
03/08/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Michaels (MIK) upgraded to Buy from Neutral at BofA/Merrill with analyst Denise Chai saying fundamentals have hit an inflection point. The analyst expects comps to improve in the second half as it is up against easy compares due to the disruption from adding flexible merchandise space to stores and the election. 2. AvalonBay (AVB) upgraded to Buy from Neutral at BofA/Merrill with analyst Juan Sanabria saying its diversified portfolio is well positioned relative to peers with its concentrated Class A, and urban core supply. 3. Weatherford (WFT) upgraded to Neutral from Sell at Clarksons Platou. 4. Bellatrix Exploration (BXE) upgraded to Speculative Buy from Hold at Canaccord with analyst Anthony Petrucci citing improved risk/reward profile. The analyst cited improved overall reserve levels and better than expected reserve value. Petrucci lowered his price target to C$1.50 from C$1.60 on Bellatrix Exploration shares. 5. ManTech (MANT) upgraded to Buy from Hold at Maxim with analyst Brian Kinstlinger saying he views the company's contract awards over the last two years as a sign that demand is strengthening and believes ManTech will gain market share. Trump administration policies will likely lead to strong market growth in 2018 and 2019, added Kinstlinger, who keeps a $44 price target on ManTech shares. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/08/17
CLKS
03/08/17
UPGRADE
CLKS
Neutral
Weatherford upgraded to Neutral from Sell at Clarksons Platou
CSX CSX

03/13/17
WELS
03/13/17
INITIATION
WELS
Outperform
CSX initiated with an Outperform at Wells Fargo
03/15/17
WOLF
03/15/17
NO CHANGE
WOLF
Wolfe cuts Railroads to Market Weight, downgrades Norfolk Southern
Wolfe Research analyst Scott Group downgraded the Railroad sector to Market Weight from Overweight saying the risk/reward profiles are more balanced following the recent expansion of valuations. Group coupled the sector cut with a downgrade of Norfolk Southern (NSC) to Peer Perform from Outperform. The analyst thinks the company's operating ratio improvement could disappoint relative to CSX (CSX). He believes CSX has the best earnings story in the space under CEO Hunter Harrison.
03/15/17
03/15/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Netflix (NFLX) upgraded to Hold from Underperform at Jefferies with analyst John Janedis saying he believes Netflix's international growth opportunity is larger than he had expected. The company's original content is performing well, mobile consumption is growing and competition appears limited, Janedis tells investors in a research note. 2. CSX (CSX) upgraded to Overweight from Neutral at Atlantic Equities. 3. Amec Foster Wheeler (AMFW) was upgraded to Neutral from Underperform at Exane BNP Paribas and to Outperform from Market Perform at Raymond James. 4. Harley-Davidson (HOG) upgraded to Neutral from Underperform at Longbow. 5. Finisar (FNSR) upgraded to Buy from Hold at Jefferies with analyst James Kisner saying the current valuation discounts no recovery in China and no resolution of recent technical issues. The analyst views the company's issues as temporary and upped his price target for the shares to $34 from $32. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/15/17
ATLE
03/15/17
UPGRADE
Target $57
ATLE
Overweight
CSX upgraded to Overweight from Neutral at Atlantic Equities
Atlantic Equities analyst Lindsay Bettiol upgraded CSX to Overweight with an increased price target of $57.
DLTR Dollar Tree
$74.30

-1.4 (-1.85%)

01/19/17
GSCO
01/19/17
DOWNGRADE
GSCO
Buy
Dollar Tree downgraded to Buy from Conviction Buy at Goldman
02/06/17
BERN
02/06/17
INITIATION
Target $63
BERN
Underperform
Dollar Tree initiated with an Underperform at Bernstein
Target $63.
12/07/16
LOOP
12/07/16
INITIATION
LOOP
Hold
Dollar Tree initiated with a Hold at Loop Capital
01/19/17
01/19/17
DOWNGRADE
Target $97

Buy
Dollar Tree removed from Conviction Buy List on sluggish trends at Goldman
As previously reported, Goldman removed Dollar Tree from the Conviction Buy List and lowered its price target to $97 from $102. Analyst Stephen Tanal expects top line trends to remain sluggish in 2017 due to capacity growth, continued food deflation, and a "hyper-competitive" environment that will likely keep same-store-sales subdued. Tanal expects costs to accelerate from minimum wage hikes, manager salary increases, and the rising costs of diesel fuel but stays Buy rated due to deal synergies that drive high visible earnings growth and benefits from an improving low-income consumer.
FEYE FireEye
$11.61

0.88 (8.20%)

03/20/17
BOFA
03/20/17
UPGRADE
Target $18
BOFA
Buy
FireEye upgraded to Buy from Neutral at BofA/Merrill
BofA/Merrill analyst Tal Liani upgraded FireEye to Buy and raised its price target to $18 from $13.50 saying the combination of low valuation and expectations, many new solutions, and recent sales leadership changes creates significant upside potential over the next two years. The analyst believes investors underappreciate FireEye's quality of management, recovery strategy, and the quality of its technology and solutions that will drive 2H 2017 growth. Liani said FireEye has some of the most advanced threat intelligence dealing with network threats, endpoint protection, and analytics and threat management tools.
03/20/17
03/20/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. BofA Merrill Lynch analyst Tal Liani upgraded FireEye (FEYE) to Buy saying the combination of low valuation and expectations, many new solutions, and recent sales leadership changes creates significant upside potential over the next two years. The analyst believes investors under-appreciate FireEye's quality of management, recovery strategy, and the quality of its technology and solutions. 2. Morgan Stanley upgraded Welltower (HCN) to Overweight from Equal Weight and raised its price target to $73 from $65, with analyst Vikram Malhotra calling the stock his preferred play on senior housing given its premium market position and a relatively younger portfolio. 3. Tiffany (TIF) upgraded to Outperform from Market Perform by William Blair analyst Dylan Carden, citing the recent stabilization of comps sales as well as upcoming easier comparisons. 4. Illumina (ILMN) upgraded to Outperform from Market Perform at Leerink by analyst Puneet Souda , who said survey data across high-productivity labs suggest earlier than expected NovaSeq upgrades in 2017 and 2018. 5. Wedbush analyst Nick Setyan upgraded Shake Shack (SHAK) to Neutral from Underperform, saying valuation is now more in line with long-term opportunities. Setyan believes same-store-sales growth headwinds and softer new unit volumes in 2017 are now well understood and raised Shake Shack's price target to $33 from $30. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
02/06/17
IMPC
02/06/17
NO CHANGE
Target $12
IMPC
In-Line
Imperial says FireEye investors could remain sidelined until billings grow again
Imperial Capital analyst Michael Kim lowered his price target on FireEye to $12 from $15 after the company reported Q4 revenue and billings that missed expectations and said he thinks investors could stay on the sidelines until billings growth returns. He keeps an In-Line rating on FireEye shares.
02/03/17
FBNS
02/03/17
DOWNGRADE
FBNS
Sector Perform
FireEye downgraded to Sector Perform from Outperform at FBN Securities
RIO Rio Tinto
$43.26

0.23 (0.53%)

12/01/16
ARGS
12/01/16
NO CHANGE
ARGS
Rio Tinto price target raised to $44 from $36 at Argus
Argus analyst John Eade raised his price target on Rio Tinto citing commodity price gains. The analyst keeps a Buy rating on the shares.
12/05/16
SBSH
12/05/16
UPGRADE
SBSH
Neutral
Rio Tinto upgraded to Neutral from Sell at Citi
12/05/16
SBSH
12/05/16
UPGRADE
SBSH
Neutral
Rio Tinto upgraded to Neutral from Sell at Citi
Citi analyst Heath Jansen upgraded Rio Tinto to Neutral after double upgrading his Metals & Mining sector view from bearish to bullish. Changes in company behavior could lead to value creation over the next few years, Jansen tells investors in a research note. The analyst has a "more robust" outlook for 2017 for the commodity complex. He raised his price target for Rio shares to GBP 33 from GBP 25.50.
12/07/16
FBCO
12/07/16
UPGRADE
FBCO
Outperform
Rio Tinto upgraded to Outperform from Neutral at Credit Suisse
Credit Suisse analyst James Gurry upgraded Rio Tinto to Outperform with a priced target of GBP 3,600.
MPEL Ticker changed to MLCO
$18.65

0.1 (0.54%)

02/06/17
JPMS
02/06/17
NO CHANGE
JPMS
Macau gaming revenue 'very strong' in early February, says JPMorgan
JPMorgan analyst DS Kim said the firm's checks indicated that Macau's gross gaming revenue for the first five days of February is estimated at MOP6.3B, which he calls a "very strong" print "no matter how we look at it." The implied average daily revenue is the second highest Chinese New Year run-rate on record, only after 2014's holiday, Kim tells investors, adding that he believes VIP demand came in particularly strong. Publicly traded companies in the Macau gaming space include Las Vegas Sands (LVS), MGM Resorts (MGM), Wynn Resorts (WYNN) and Melco Crown (MPEL).
01/25/17
01/25/17
UPGRADE
Target $16

Neutral
Melco Crown upgraded to Neutral on stronger Manila growth at Nomura
As previously reported, Nomura upgraded Melco Crown to Neutral from Reduce and raised its price target to $16 from $14. Analyst Harry Curtis said shares have corrected 20% since April 24 and not longer sees downside risks from VIP and premium mass-led stabilization in Macau and stronger-than-expected GGR growth in Manila where the overall demand may continue to increase more than the supply growth.
02/16/17
DBAB
02/16/17
NO CHANGE
Target $22.8
DBAB
Buy
Melco Crown a solid operator trading at a discount, says Deutsche Bank
Deutsche Bank analyst Karen Tang said Melco Crown's Q4 Macau property EBITDA actually grew 10% sequentially after adjusting for bad luck, and noted that City of Dreams managed to gain mass market share despite the opening of two new casinos. While upcoming regulatory changes, likely to be passed in mid-2017, will ban smoking at CoD's premium mass areas, this risk is largely priced in given Melco's discount valuation, added Tang, who raised her estimates for Melco and keeps a Buy rating and $22.80 price target on the stock.
02/13/17
MSCO
02/13/17
UPGRADE
MSCO
Overweight
Melco Crown upgraded to Overweight from Equal Weight at Morgan Stanley
GSAT Globalstar
$1.57

0.1 (6.80%)

02/24/17
CHDN
02/24/17
UPGRADE
CHDN
Buy
Globalstar upgraded to Buy from Neutral at Chardan
06/13/16
CHDN
06/13/16
DOWNGRADE
CHDN
Neutral
Globalstar downgraded to Neutral from Buy at Chardan
06/13/16
CHDN
06/13/16
DOWNGRADE
CHDN
Neutral
Globalstar downgraded on lower odds of TLPS passing at Chardan
As previously reported, Chardan downgraded Globalstar to Neutral from Buy, as analyst James McIlree argues that the odds of TLPS passing have diminished greatly after one FCC commissioner announced he had voted against the TLPS proposal and reports indicated that another also voted against TLPS. Even if TLPS does pass it seems it will be a provisional approval, or for test period, which would be a positive step but would also make it more difficult for the company to attract partners, McIlree tells investors.
FTV Fortive
$59.00

-0.58 (-0.97%)

01/13/17
FBCO
01/13/17
UPGRADE
FBCO
Outperform
Fortive upgraded to Outperform from Neutral at Credit Suisse
01/13/17
FBCO
01/13/17
UPGRADE
Target $60
FBCO
Outperform
Fortive upgraded to Outperform on valuation, M&A catalysts at Credit Suisse
As previously reported, Credit Suisse upgraded Fortive to Outperform from Neutral and raised its price target to $60 from $54. Analyst Julian Mitchell thinks recent underperformance has created an attractive entry point and views shares as an underappreciated way of playing a short-cycle industrial recovery as well as potential benefits from the incoming Administration. Mitchell expects M&A activity to pick up materially in 2017, which should prove to be a meaningful catalysts for the shares.
01/17/17
OPCO
01/17/17
INITIATION
OPCO
Perform
Fortive initiated with a Perform at Oppenheimer
Oppenheimer analyst Jim Giannakouros initiated Fortive with a Perform rating.
01/18/17
01/18/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. AutoZone (AZO) and O'Reilly Automotive (ORLY) were initiated with a Buy at Guggenheim, while the firm initiated Advance Auto Parts (AAP) with a Neutral. 2 Kansas City Southern (KSU) was initiated with a Buy at Buckingham, while the firm initiated Norfolk Southern (NSC) and Union Pacific (UNP) with a Neutral. 3. Fortive (FTV) initiated with a Perform at Oppenheimer. 4. Halliburton (HAL) was initiated with a Buy at SunTrust, while the firm initiated Helmerich & Payne (HP) with a Sell. The firm also initiated Baker Hughes (BHI) and Schlumberger (SLB) with a Hold. 5. Expedia (EXPE) was initiated with a Strong Buy at Miller Tabak, while the firm initiated Priceline (PCLN) with a Buy and TripAdvisor (TRIP) with a Hold. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

WAC

Walter Investment

$0.51

-0.0056 (-1.09%)

10:24
10/21/17
10/21
10:24
10/21/17
10:24
Hot Stocks
Walter Investment reaches agreement on financial restructuring »

Walter Investment has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMST

TimkenSteel

$17.57

0.19 (1.09%)

10:18
10/21/17
10/21
10:18
10/21/17
10:18
Hot Stocks
Tentative agreement between TimkenSteel, United Steelworkers voted down »

TimkenSteel employees who…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

AGEN

Agenus

$4.33

-0.14 (-3.13%)

, GSK

GlaxoSmithKline

$40.84

-0.26 (-0.63%)

10:15
10/21/17
10/21
10:15
10/21/17
10:15
Hot Stocks
FDA approves GlaxoSmithKline shingles vaccine with Agenus QS-21 Stimulon »

Agenus (AGEN) has…

AGEN

Agenus

$4.33

-0.14 (-3.13%)

GSK

GlaxoSmithKline

$40.84

-0.26 (-0.63%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 25

    Oct

  • 06

    Nov

MS

Morgan Stanley

$50.68

0.89 (1.79%)

10:06
10/21/17
10/21
10:06
10/21/17
10:06
Periodicals
Another 20% gain in Morgan Stanley stock likely, Barron's says »

In a follow-up story,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

SSNLF

Samsung

10:02
10/21/17
10/21
10:02
10/21/17
10:02
Periodicals
Samsung has lots of upside driven by chips/screens, Barron's says »

Samsung stock is up 50%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 30

    Oct

DLAKY

Lufthansa

$30.28

0.2 (0.66%)

09:56
10/21/17
10/21
09:56
10/21/17
09:56
Periodicals
Lufthansa has more room to climb, Barron's says »

Amid competitor's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$59.90

0.12 (0.20%)

, DAL

Delta Air Lines

$53.27

1 (1.91%)

09:51
10/21/17
10/21
09:51
10/21/17
09:51
Periodicals
Market pounds United, sees American/Delta as possibly safe bets, Barron's says »

United Continental's…

UAL

United Continental

$59.90

0.12 (0.20%)

DAL

Delta Air Lines

$53.27

1 (1.91%)

AAL

American Airlines

$51.93

0.42 (0.82%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 26

    Oct

  • 01

    Nov

CZR

Caesars

$12.20

0.15 (1.24%)

09:45
10/21/17
10/21
09:45
10/21/17
09:45
Periodicals
Caesars looks ready to grow again, Barron's says »

After a disastrous 2008…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 08

    Nov

DWDP

DowDuPont

$71.18

0.29 (0.41%)

09:40
10/21/17
10/21
09:40
10/21/17
09:40
Periodicals
DowDuPont shares likely to return as much as 30% over next year, Barron's says »

If DowDuPont can cut $3B…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COH

Coach

$40.35

0.88 (2.23%)

09:29
10/21/17
10/21
09:29
10/21/17
09:29
Periodicals
Coach shares look undervalued, could rise nearly 30%, Barron's says »

Coach, which has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNC

Centene

$96.50

1.8 (1.90%)

, MOH

Molina Healthcare

$64.40

0.76 (1.19%)

09:24
10/21/17
10/21
09:24
10/21/17
09:24
Hot Stocks
Week in review: How Trump's policies moved stocks »

Catch up on the top…

CNC

Centene

$96.50

1.8 (1.90%)

MOH

Molina Healthcare

$64.40

0.76 (1.19%)

CI

Cigna

$191.42

3.2 (1.70%)

ANTM

Anthem

$194.69

1.49 (0.77%)

AET

Aetna

$160.84

3.2 (2.03%)

HNT

Health Net

HUM

Humana

$245.81

3.12 (1.29%)

UNH

UnitedHealth

$207.49

4.24 (2.09%)

WCG

WellCare

$180.52

3.28 (1.85%)

CYH

Community Health

$6.44

0.24 (3.87%)

HCA

HCA Healthcare

$81.05

1.26 (1.58%)

LPNT

LifePoint

$58.35

0.5 (0.86%)

THC

Tenet

$14.66

1.31 (9.81%)

UHS

Universal Health

$112.85

2.31 (2.09%)

GOOG

Alphabet

$988.20

3.75 (0.38%)

GOOGL

Alphabet Class A

$1,005.07

3.23 (0.32%)

MSFT

Microsoft

$78.81

0.9 (1.16%)

FB

Facebook

$174.98

0.42 (0.24%)

INTC

Intel

$40.43

0.34 (0.85%)

IBM

IBM

$162.07

1.17 (0.73%)

MAR

Marriott

$115.02

-0.18 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 30

    Oct

  • 30

    Oct

  • 31

    Oct

  • 31

    Oct

  • 31

    Oct

  • 31

    Oct

  • 01

    Nov

  • 01

    Nov

  • 01

    Nov

  • 02

    Nov

  • 02

    Nov

  • 02

    Nov

  • 02

    Nov

  • 03

    Nov

  • 06

    Nov

  • 08

    Nov

  • 08

    Nov

  • 08

    Nov

  • 15

    Nov

  • 15

    Nov

  • 29

    Nov

  • 30

    Nov

  • 18

    Mar

ETFC

E-Trade

$43.20

-0.49 (-1.12%)

08:55
10/21/17
10/21
08:55
10/21/17
08:55
Conference/Events
E-Trade to hold an education day »

Chicago Education Day is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 07

    Nov

08:45
10/21/17
10/21
08:45
10/21/17
08:45
General news
Breaking General news story  »

New York Federal Reserve…

FB

Facebook

$174.98

0.42 (0.24%)

, AMZN

Amazon.com

$982.91

-3.7 (-0.38%)

08:25
10/21/17
10/21
08:25
10/21/17
08:25
Periodicals
Regulators inquiries fuel speculation about big tech breakup, Barron's says »

Facebook (FB), Amazon…

FB

Facebook

$174.98

0.42 (0.24%)

AMZN

Amazon.com

$982.91

-3.7 (-0.38%)

GOOG

Alphabet

$988.20

3.75 (0.38%)

GOOGL

Alphabet Class A

$1,005.07

3.23 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 26

    Oct

  • 26

    Oct

  • 01

    Nov

  • 08

    Nov

  • 15

    Nov

  • 29

    Nov

  • 18

    Mar

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

, AIMT

Aimmune

$25.66

-0.06 (-0.23%)

07:58
10/21/17
10/21
07:58
10/21/17
07:58
Hot Stocks
DBV believes FDA suggested continue moving forward with Viaskin »

DBV Technologies (DBVT)…

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

AIMT

Aimmune

$25.66

-0.06 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

04:55
10/21/17
10/21
04:55
10/21/17
04:55
General news
Breaking General news story  »

New York Federal Reserve…

ETFC

E-Trade

$43.20

-0.49 (-1.12%)

04:55
10/21/17
10/21
04:55
10/21/17
04:55
Conference/Events
E-Trade to hold an education day »

Chicago Education Day is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 07

    Nov

19:15
10/20/17
10/20
19:15
10/20/17
19:15
General news
Breaking General news story  »

Federal Reserve Chair…

ATRS

Antares Pharma

$2.18

0.06 (2.83%)

18:59
10/20/17
10/20
18:59
10/20/17
18:59
Hot Stocks
FDA cannot approve Antares Pharma's Xyosted NDA »

Antares Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

18:55
10/20/17
10/20
18:55
10/20/17
18:55
Conference/Events
Federal Reserve Chairperson delivers a lecture at NEC Dinner »

Federal Reserve…

SHIP

Seanergy Marine

$1.24

0.0199 (1.63%)

17:50
10/20/17
10/20
17:50
10/20/17
17:50
Syndicate
Breaking Syndicate news story on Seanergy Marine »

Seanergy Marine files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HLI

Houlihan Lokey

$41.56

0.18 (0.43%)

17:49
10/20/17
10/20
17:49
10/20/17
17:49
Syndicate
Breaking Syndicate news story on Houlihan Lokey »

Houlihan Lokey files to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

GEO

Geo Group

$26.20

0.2 (0.77%)

17:48
10/20/17
10/20
17:48
10/20/17
17:48
Syndicate
Breaking Syndicate news story on Geo Group »

Geo Group files automatic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

, AIMT

Aimmune

$25.66

-0.06 (-0.23%)

17:37
10/20/17
10/20
17:37
10/20/17
17:37
Hot Stocks
DBV sinks following peanut allergy trial miss, Aimmune soars »

Shares of DBV…

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

AIMT

Aimmune

$25.66

-0.06 (-0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Nov

KALV

KalVista

$11.26

1.99 (21.47%)

, DBVT

DBV Technologies

$48.07

0.92 (1.95%)

17:24
10/20/17
10/20
17:24
10/20/17
17:24
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: KalVista (KALV),…

KALV

KalVista

$11.26

1.99 (21.47%)

DBVT

DBV Technologies

$48.07

0.92 (1.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.